Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature

NCT00198380 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Pneumonic-type Adenocarcinoma (P-ADC)
Lung Adenocarcinoma With Bronchiolo-alveolar Feature

Interventions

DRUG: Gefitinib

Sponsor

Intergroupe Francophone de Cancerologie Thoracique

Collaborators

[object Object]